The Latest in CLL

FDA approves new drug for CLL/SLL and follicular lymphoma

September 25, 2018

FDA approves new hairy cell leukemia drug

September 13, 2018

CLL

Venetoclax label now includes MRD data

September 12, 2018

RESONATE-2 update: First-line ibrutinib has sustained efficacy in older CLL patients

September 6, 2018

CLL

Combo treatment yields MRD-negative remissions in CLL

August 23, 2018

CLL

Caution urged over real-world bleeding risk with ibrutinib

August 14, 2018

New chronic lymphocytic leukemia guidelines from the UK

August 8, 2018

CLL

Isavuconazole resolved invasive fungal disease in patients on ibrutinib

July 29, 2018

CLL

Ibrutinib stacks up well on safety in pooled analysis

July 20, 2018

Ibrutinib/venetoclax shows early promise in relapsed CLL

July 11, 2018

CLL

Rapid venetoclax dose escalation aids relapsed CLL

July 5, 2018

CLL

Is CLL chemoimmunotherapy dead? Not yet

June 20, 2018

CLL

FDA grants regular approval to venetoclax for CLL/SLL

June 8, 2018

CLL

Venetoclax plus ibrutinib yields encouraging MRD results in first-line CLL

June 8, 2018

CLL

Older CLL and NHL patients are more vulnerable to toxicities

May 23, 2018

CLL